Back to trials View on registry
recruiting
Phase 2
NCT04891068
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer
Sponsored by University of Illinois at Chicago
Why you can trust this information
Registry sourcesNot yet reconciled
Source last updatedNot reported
Clintriva indexed9/27/2026, 9:27:08 PM
Registry records0
Relationships needing review0
Identity-resolution confidence concerns registry/entity resolution and does not determine clinical eligibility.
Interested in this trial?
Express your interest and we'll connect you with the trial team.
Your selected profile and contact information may be shared with an authorised trial site, sponsor, or Clintriva coordination team for trial contact and pre-screening. Expressing interest does not mean you are eligible or enrolled.
Quick Facts
Start DateJan 10, 2022
CompletionMay 1, 2027
Enrollment0/40
CountryUnited States
Conditions
Breast Cancer Invasive
Early-stage Breast Cancer
High Risk Breast Carcinoma